Symbols / DVA Stock $187.91 -1.00% DaVita Inc.

Healthcare • Medical Care Facilities • United States • NYQ
DVA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO Mr. Javier J. Rodriguez
Exch · Country NYQ · United States
Market Cap 12.06B
Enterprise Value 26.54B
Income 756.42M
Sales 13.84B
FCF (ttm) 999.66M
Book/sh -11.41
Cash/sh 10.38
Employees 78,000
Insider 10d —
IPO Oct 31, 1995
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 18.10
Forward P/E 10.94
PEG 0.60
P/S 0.87
P/B -16.46
P/C —
EV/EBITDA 9.50
EV/Sales 1.92
Quick Ratio 1.28
Current Ratio 1.42
Debt/Eq 1,261.33
LT Debt/Eq —
EPS (ttm) 10.38
EPS next Y 17.18
EPS Growth 43.50%
Revenue Growth 6.00%
EPS Gr Q/Q 21.20%
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-05
ROA 7.50%
ROE 80.98%
ROIC —
Gross Margin 32.45%
Oper. Margin 13.86%
Profit Margin 5.65%
Shs Outstand 64.19M
Shs Float 34.09M
Insider Own 50.55%
Instit Own 52.05%
Short Float 17.30%
Short Ratio 6.07
Short Interest 5.68M
52W High 202.69
vs 52W High -7.29%
52W Low 101.00
vs 52W Low 86.05%
Beta 0.84
Impl. Vol. 39.33%
Rel Volume 0.61
Avg Volume 871.27K
Volume 532.65K
Target (mean) $193.71
Tgt Median $201.00
Tgt Low $145.00
Tgt High $235.00
# Analysts 7
Recom None
Prev Close $189.81
Price $187.91
Change -1.00%
About

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$193.71
Mean price target
2. Current target
$187.91
Latest analyst target
3. DCF / Fair value
$280.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$187.91
Low
$145.00
High
$235.00
Mean
$193.71

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-11 main TD Cowen Hold → Hold $201
2026-05-08 main Truist Securities Hold → Hold $205
2026-05-08 main Barclays Equal-Weight → Equal-Weight $194
2026-05-07 main UBS Buy → Buy $235
2026-05-06 up Deutsche Bank Hold → Buy $220
2026-02-04 main UBS Buy → Buy $190
2026-02-03 main Barclays Equal-Weight → Equal-Weight $158
2025-11-03 main TD Cowen Hold → Hold $133
2025-10-30 main Barclays Equal-Weight → Equal-Weight $143
2025-10-09 main Barclays Equal-Weight → Equal-Weight $149
2025-09-10 main B of A Securities Underperform → Underperform $140
2025-08-07 main Barclays Equal-Weight → Equal-Weight $160
2025-05-19 main Truist Securities Hold → Hold $164
2025-02-18 main Barclays Equal-Weight → Equal-Weight $169
2024-10-31 main Barclays Equal-Weight → Equal-Weight $164
2024-10-07 main Truist Securities Hold → Hold $175
2024-08-20 main Truist Securities Hold → Hold $165
2024-08-08 main UBS Buy → Buy $175
2024-08-07 main B of A Securities Underperform → Underperform $145
2024-07-24 main TD Cowen Hold → Hold $150
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-26 YALE PHYLLIS R Director — 5,038 $0.00 $0
2026-05-15 HEARTY JAMES O Officer — 15,000 $193.98 $2,909,745
2026-05-15 SCHECHTER ADAM H Director — 250 $0.00 $0
2026-05-15 YALE PHYLLIS R Director — 250 $0.00 $0
2026-05-15 DESOER BARBARA J Director — 250 $0.00 $0
2026-05-15 ARWAY PAMELA M. Director — 250 $0.00 $0
2026-05-15 MOORE GREGORY J Director — 250 $0.00 $0
2026-05-15 PULLIN DENNIS W Director — 250 $0.00 $0
2026-05-15 SCHOPPERT WENDY LEE Director — 250 $0.00 $0
2026-05-15 HOLLAR JASON M Director — 250 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
13,643.07
+6.46%
12,815.55
+5.56%
12,140.15
+4.57%
11,609.89
Operating Revenue
13,007.19
+6.09%
12,260.38
+5.92%
11,574.94
+3.57%
11,176.46
Cost Of Revenue
9,243.48
+7.50%
8,598.52
+3.35%
8,319.72
+1.34%
8,209.55
Reconciled Cost Of Revenue
9,243.48
+7.50%
8,598.52
+3.35%
8,319.72
+1.34%
8,209.55
Gross Profit
4,399.59
+4.33%
4,217.03
+10.38%
3,820.43
+12.35%
3,400.34
Operating Expense
2,388.98
+5.60%
2,262.20
+1.93%
2,219.43
+6.30%
2,087.80
Selling General And Administration
1,673.63
+8.79%
1,538.34
+4.37%
1,473.98
+8.77%
1,355.20
General And Administrative Expense
1,673.63
+8.79%
1,538.34
+4.37%
1,473.98
+8.77%
1,355.20
Other Gand A
1,673.63
+8.79%
1,538.34
+4.37%
1,473.98
+8.77%
1,355.20
Total Expenses
11,632.45
+7.11%
10,860.72
+3.05%
10,539.14
+2.35%
10,297.35
Operating Income
2,010.62
+2.85%
1,954.83
+22.10%
1,601.00
+21.98%
1,312.54
Total Operating Income As Reported
2,043.62
-2.24%
2,090.48
+30.43%
1,602.78
+19.69%
1,339.06
EBITDA
2,642.10
-3.03%
2,724.72
+17.39%
2,321.09
+12.90%
2,055.90
Normalized EBITDA
2,656.28
+0.80%
2,635.07
+11.89%
2,355.13
+14.55%
2,055.90
Reconciled Depreciation
715.35
-1.18%
723.86
-2.90%
745.44
+1.75%
732.60
EBIT
1,926.75
-3.70%
2,000.86
+26.99%
1,575.64
+19.07%
1,323.30
Total Unusual Items
-14.18
-115.81%
89.65
+363.34%
-34.05
0.00
Total Unusual Items Excluding Goodwill
-14.18
-115.81%
89.65
+363.34%
-34.05
0.00
Special Income Charges
-14.18
-115.81%
89.65
+363.34%
-34.05
0.00
Other Special Charges
14.18
-28.44%
19.81
+148.84%
7.96
—
Impairment Of Capital Assets
0.00
0.00
-100.00%
26.08
0.00
Restructuring And Mergern Acquisition
0.00
+100.00%
-109.47
0.00
0.00
Net Income
746.80
-20.24%
936.34
+35.40%
691.53
+23.40%
560.40
Pretax Income
1,346.82
-11.99%
1,530.39
+30.01%
1,177.09
+21.82%
966.28
Net Non Operating Interest Income Expense
-579.93
-23.27%
-470.47
-18.04%
-398.55
-11.63%
-357.02
Interest Expense Non Operating
579.93
+23.27%
470.47
+18.04%
398.55
+11.63%
357.02
Net Interest Income
-579.93
-23.27%
-470.47
-18.04%
-398.55
-11.63%
-357.02
Interest Expense
579.93
+23.27%
470.47
+18.04%
398.55
+11.63%
357.02
Other Income Expense
-83.87
-282.18%
46.03
+281.54%
-25.36
-335.78%
10.76
Other Non Operating Income Expenses
-102.69
-47.10%
-69.81
-264.02%
-19.18
-21.64%
-15.77
Gain On Sale Of Business
—
—
—
0.00
Tax Provision
293.11
+4.81%
279.66
+27.05%
220.12
+11.12%
198.09
Tax Rate For Calcs
0.00
+19.09%
0.00
-24.80%
0.00
+18.54%
0.00
Tax Effect Of Unusual Items
-3.09
-118.83%
16.38
+298.03%
-8.27
0.00
Net Income Including Noncontrolling Interests
1,078.72
-13.75%
1,250.74
+30.70%
956.98
+22.43%
781.64
Net Income From Continuing Operation Net Minority Interest
721.80
-22.91%
936.34
+35.40%
691.53
+26.44%
546.95
Net Income From Continuing And Discontinued Operation
746.80
-20.24%
936.34
+35.40%
691.53
+23.40%
560.40
Net Income Continuous Operations
1,053.72
-15.75%
1,250.74
+30.70%
956.98
+24.58%
768.19
Net Income Discontinuous Operations
25.00
0.00
0.00
-100.00%
13.45
Minority Interests
-331.91
-5.57%
-314.39
-18.44%
-265.44
-19.98%
-221.24
Normalized Income
732.90
-15.08%
863.07
+20.32%
717.31
+31.15%
546.95
Net Income Common Stockholders
746.80
-20.24%
936.34
+35.40%
691.53
+23.40%
560.40
Diluted EPS
9.84
-8.29%
10.73
+44.61%
7.42
+26.84%
5.85
Basic EPS
10.06
-8.71%
11.02
+44.62%
7.62
+26.37%
6.03
Basic Average Shares
74.23
-12.66%
84.99
-6.39%
90.79
-2.37%
92.99
Diluted Average Shares
75.89
-13.05%
87.27
-6.34%
93.18
-2.77%
95.83
Diluted NI Availto Com Stockholders
746.80
-20.24%
936.34
+35.40%
691.53
+23.40%
560.40
Depreciation Amortization Depletion Income Statement
715.35
-1.18%
723.86
-2.90%
745.44
+1.75%
732.60
Depreciation And Amortization In Income Statement
715.35
-1.18%
723.86
-2.90%
745.44
+1.75%
732.60
Earnings From Equity Interest
33.00
+26.01%
26.19
-6.01%
27.86
+5.07%
26.52
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2021-12-31
Total Assets
17,480.10
+1.13%
17,285.27
+2.32%
16,893.58
—
Current Assets
4,058.00
+8.33%
3,746.07
+19.38%
3,137.91
—
Cash Cash Equivalents And Short Term Investments
700.74
-17.17%
846.00
+116.00%
391.67
—
Cash And Cash Equivalents
676.44
-14.91%
794.93
+109.16%
380.06
—
Other Short Term Investments
24.30
-52.41%
51.06
+339.83%
11.61
—
Receivables
2,959.04
+15.69%
2,557.68
+5.87%
2,415.91
—
Accounts Receivable
2,414.69
+12.47%
2,146.97
+8.06%
1,986.86
—
Gross Accounts Receivable
—
—
—
1,957.58
Allowance For Doubtful Accounts Receivable
—
—
—
0.00
Other Receivables
494.41
+29.03%
383.17
-9.35%
422.67
—
Taxes Receivable
49.94
+81.36%
27.54
+331.11%
6.39
—
Inventory
160.63
+19.37%
134.56
-5.97%
143.10
—
Prepaid Assets
—
—
—
72.52
Restricted Cash
81.31
-4.22%
84.89
+0.38%
84.57
—
Other Current Assets
156.28
+27.11%
122.95
+19.78%
102.64
—
Total Non Current Assets
13,422.10
-0.86%
13,539.20
-1.57%
13,755.67
—
Net PPE
5,210.15
-2.33%
5,334.47
-4.31%
5,574.90
—
Gross PPE
11,812.28
+1.85%
11,597.18
+2.32%
11,334.41
—
Accumulated Depreciation
-6,602.13
-5.42%
-6,262.70
-8.74%
-5,759.51
—
Properties
0.00
0.00
0.00
—
Land And Improvements
40.49
-19.29%
50.17
+42.47%
35.22
—
Buildings And Improvements
402.62
-6.15%
428.99
-1.71%
436.46
—
Construction In Progress
122.36
-8.21%
133.31
-24.75%
177.15
—
Other Properties
6,934.15
+1.91%
6,803.95
+2.68%
6,626.60
—
Leases
4,312.65
+3.15%
4,180.75
+3.00%
4,058.99
—
Goodwill And Other Intangible Assets
7,767.22
+2.57%
7,572.65
+3.51%
7,315.78
—
Goodwill
7,545.10
+2.30%
7,375.22
+3.69%
7,112.56
—
Other Intangible Assets
222.12
+12.51%
197.43
-2.85%
203.22
—
Investments And Advances
198.22
-46.48%
370.34
-37.63%
593.74
—
Long Term Equity Investment
157.25
-53.29%
336.68
-38.32%
545.85
—
Other Non Current Assets
246.52
-5.81%
261.73
-3.51%
271.25
—
Total Liabilities Net Minority Interest
16,321.67
+7.42%
15,193.92
+7.38%
14,150.23
—
Current Liabilities
3,141.63
+5.66%
2,973.41
+12.53%
2,642.21
—
Payables And Accrued Expenses
1,171.18
+54.08%
760.09
+8.48%
700.68
—
Payables
982.13
+59.30%
616.51
+4.42%
590.43
—
Accounts Payable
696.15
+27.22%
547.20
+6.35%
514.53
—
Current Accrued Expenses
189.05
+31.67%
143.58
+30.23%
110.25
—
Pensionand Other Post Retirement Benefit Plans Current
793.48
-0.88%
800.48
+6.36%
752.60
—
Total Tax Payable
86.04
+24.14%
69.31
-8.68%
75.90
—
Income Tax Payable
24.36
+136.43%
10.30
-63.86%
28.51
—
Current Debt And Capital Lease Obligation
534.68
-21.52%
681.28
+31.60%
517.70
—
Current Debt
109.20
-59.68%
270.87
+119.68%
123.30
—
Other Current Borrowings
109.20
-59.68%
270.87
+119.68%
123.30
—
Current Capital Lease Obligation
425.48
+3.67%
410.41
+4.06%
394.40
—
Other Current Liabilities
642.29
-12.20%
731.56
+8.99%
671.24
—
Total Non Current Liabilities Net Minority Interest
13,180.03
+7.85%
12,220.51
+6.19%
11,508.01
—
Long Term Debt And Capital Lease Obligation
12,339.65
+8.38%
11,385.56
+7.42%
10,598.72
—
Long Term Debt
10,163.99
+10.77%
9,175.90
+10.98%
8,268.33
—
Long Term Capital Lease Obligation
2,175.66
-1.54%
2,209.66
-5.18%
2,330.39
—
Non Current Deferred Liabilities
756.87
+13.75%
665.36
-8.38%
726.22
—
Non Current Deferred Taxes Liabilities
756.87
+13.75%
665.36
-8.38%
726.22
—
Other Non Current Liabilities
83.52
-50.75%
169.59
-7.37%
183.07
—
Preferred Securities Outside Stock Equity
—
—
—
1,434.83
Stockholders Equity
-651.08
-637.54%
121.12
-88.53%
1,056.10
—
Common Stock Equity
-651.08
-637.54%
121.12
-88.53%
1,056.10
—
Capital Stock
0.07
-23.33%
0.09
+1.12%
0.09
—
Common Stock
0.07
-23.33%
0.09
+1.12%
0.09
—
Preferred Stock
0.00
0.00
0.00
—
Share Issued
68.55
-24.15%
90.37
+1.74%
88.82
—
Ordinary Shares Number
68.55
-14.88%
80.54
-9.33%
88.82
—
Treasury Shares Number
0.00
-100.00%
9.83
0.00
-100.00%
13.88
Additional Paid In Capital
0.00
-100.00%
286.27
-43.85%
509.80
—
Retained Earnings
-328.43
-121.40%
1,534.63
+156.50%
598.29
—
Gains Losses Not Affecting Retained Earnings
-122.78
+60.49%
-310.80
-496.72%
-52.08
—
Treasury Stock
199.94
-85.61%
1,389.07
0.00
—
Minority Interest
1,809.52
-8.16%
1,970.23
+16.77%
1,687.25
—
Other Equity Adjustments
-122.78
+60.49%
-310.80
-496.72%
-52.08
—
Total Equity Gross Minority Interest
1,158.44
-44.61%
2,091.35
-23.77%
2,743.35
—
Total Capitalization
9,512.91
+2.32%
9,297.02
-0.29%
9,324.43
—
Working Capital
916.37
+18.60%
772.66
+55.88%
495.69
—
Invested Capital
9,622.11
+0.57%
9,567.89
+1.27%
9,447.73
—
Total Debt
12,874.33
+6.69%
12,066.84
+8.55%
11,116.42
—
Net Debt
9,596.75
+10.92%
8,651.84
+7.99%
8,011.57
—
Capital Lease Obligations
2,601.14
-0.72%
2,620.07
-3.84%
2,724.79
—
Net Tangible Assets
-8,418.30
-12.97%
-7,451.52
-19.04%
-6,259.69
—
Tangible Book Value
-8,418.30
-12.97%
-7,451.52
-19.04%
-6,259.69
—
Available For Sale Securities
36.55
+8.58%
33.66
+2.34%
32.89
—
Dueto Related Parties Current
199.94
0.00
—
—
Held To Maturity Securities
4.42
0.00
-100.00%
15.00
—
Interest Payable
97.33
+60.77%
60.54
+68.57%
35.91
—
Investmentin Financial Assets
40.97
+21.71%
33.66
-29.71%
47.89
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
1,886.50
-6.70%
2,022.04
-1.80%
2,059.03
+31.60%
1,564.57
Cash Flow From Continuing Operating Activities
1,886.50
-6.70%
2,022.04
-1.80%
2,059.03
+31.60%
1,564.57
Net Income From Continuing Operations
1,078.72
-13.75%
1,250.74
+30.70%
956.98
+22.43%
781.64
Depreciation Amortization Depletion
715.35
-1.18%
723.86
-2.90%
745.44
+1.75%
732.60
Depreciation And Amortization
715.35
-1.18%
723.86
-2.90%
745.44
+1.75%
732.60
Other Non Cash Items
-17.55
-230.83%
13.41
+250.08%
-8.94
-141.20%
21.69
Stock Based Compensation
139.95
+36.16%
102.79
-8.53%
112.38
+17.76%
95.43
Asset Impairment Charge
0.00
0.00
-100.00%
26.08
0.00
Deferred Tax
86.57
+249.68%
-57.84
-46.97%
-39.35
+47.99%
-75.67
Deferred Income Tax
86.57
+249.68%
-57.84
-46.97%
-39.35
+47.99%
-75.67
Operating Gains Losses
146.70
+676.19%
18.90
-73.72%
71.91
+719.66%
8.77
Gain Loss On Investment Securities
134.31
+15.95%
115.84
+78.83%
64.78
+638.37%
8.77
Change In Working Capital
-263.24
-782.74%
-29.82
-115.33%
194.53
+192508.91%
0.10
Change In Receivables
-210.63
-607.63%
-29.77
-117.27%
172.36
+216.15%
-148.39
Changes In Account Receivables
-210.63
-607.63%
-29.77
-117.27%
172.36
+216.15%
-148.39
Change In Inventory
-19.95
-211.19%
17.94
+155.84%
-32.13
-4144.65%
-0.76
Change In Payables And Accrued Expense
128.30
+7451.68%
1.70
-93.68%
26.89
-69.26%
87.48
Change In Payable
128.30
+7451.68%
1.70
-93.68%
26.89
-69.26%
87.48
Change In Account Payable
128.30
+7451.68%
1.70
-93.68%
26.89
-69.26%
87.48
Change In Other Working Capital
26.20
+188.74%
-29.53
-151.10%
57.78
+453.81%
10.43
Change In Other Current Assets
-164.55
-444.33%
-30.23
+38.59%
-49.23
-113.89%
-23.02
Change In Other Current Liabilities
-22.61
-156.45%
40.06
+112.34%
18.87
-74.63%
74.35
Investing Cash Flow
-654.95
+15.10%
-771.43
+0.05%
-771.80
-22.44%
-630.35
Cash Flow From Continuing Investing Activities
-654.95
+15.10%
-771.43
+0.05%
-771.80
-22.44%
-630.35
Net PPE Purchase And Sale
-575.86
-3.68%
-555.44
+2.21%
-567.99
+5.87%
-603.43
Purchase Of PPE
-575.86
-3.68%
-555.44
+2.21%
-567.99
+5.87%
-603.43
Capital Expenditure
-575.86
-3.68%
-555.44
+2.21%
-567.99
+5.87%
-603.43
Net Investment Purchase And Sale
29.70
+981.97%
2.75
-95.66%
63.26
+208.16%
-58.49
Purchase Of Investment
-22.44
+8.27%
-24.46
+47.68%
-46.75
+64.96%
-133.39
Sale Of Investment
52.14
+91.65%
27.20
-75.27%
110.00
+46.86%
74.91
Net Business Purchase And Sale
-144.50
+42.49%
-251.27
+16.96%
-302.60
-239.26%
-89.19
Purchase Of Business
-144.50
+42.49%
-251.27
+16.96%
-302.60
-239.26%
-89.19
Gain Loss On Sale Of Business
0.00
+100.00%
-109.47
0.00
0.00
Net Other Investing Changes
34.17
+32.14%
25.86
-15.51%
30.61
-73.79%
116.80
Financing Cash Flow
-1,374.78
-68.28%
-816.94
+30.21%
-1,170.49
-4.40%
-1,121.13
Cash Flow From Continuing Financing Activities
-1,374.78
-68.28%
-816.94
+30.21%
-1,170.49
-4.40%
-1,121.13
Net Issuance Payments Of Debt
823.43
-25.76%
1,109.10
+300.70%
-552.62
-4799.50%
-11.28
Issuance Of Debt
5,612.28
-15.28%
6,624.31
+168.37%
2,468.34
+3.14%
2,393.12
Repayment Of Debt
-4,788.85
+13.17%
-5,515.21
-82.57%
-3,020.96
-25.64%
-2,404.39
Long Term Debt Issuance
5,612.28
-15.28%
6,624.31
+168.37%
2,468.34
+3.14%
2,393.12
Long Term Debt Payments
-4,788.85
+13.17%
-5,515.21
-82.57%
-3,020.96
-25.64%
-2,404.39
Net Long Term Debt Issuance
823.43
-25.76%
1,109.10
+300.70%
-552.62
-4799.50%
-11.28
Net Common Stock Issuance
-1,793.00
-29.37%
-1,385.93
-409.12%
-272.22
+65.26%
-783.65
Common Stock Payments
-1,793.00
-29.37%
-1,385.93
-409.12%
-272.22
+66.07%
-802.23
Repurchase Of Capital Stock
-1,793.00
-29.37%
-1,385.93
-409.12%
-272.22
+66.07%
-802.23
Proceeds From Stock Option Exercised
23.29
+13.87%
20.45
+21.02%
16.90
—
Net Other Financing Charges
-428.51
+23.56%
-560.55
-54.61%
-362.56
-11.15%
-326.20
Changes In Cash
-143.23
-133.03%
433.67
+271.50%
116.74
+162.46%
-186.91
Effect Of Exchange Rate Changes
21.15
+214.45%
-18.48
-307.44%
8.91
+130.65%
-29.07
Beginning Cash Position
879.83
+89.36%
464.63
+37.06%
338.99
-38.92%
554.96
End Cash Position
757.75
-13.88%
879.83
+89.36%
464.63
+37.06%
338.99
Free Cash Flow
1,310.64
-10.63%
1,466.60
-1.64%
1,491.05
+55.13%
961.14
Interest Paid Supplemental Data
515.50
+21.76%
423.36
+9.21%
387.66
+10.45%
351.00
Income Tax Paid Supplemental Data
176.69
-54.45%
387.94
+44.70%
268.09
-22.16%
344.43
Common Stock Issuance
—
20.45
+21.02%
16.90
-9.03%
18.58
Dividends Received CFI
1.54
-76.95%
6.68
+35.97%
4.91
+24.00%
3.96
Earnings Losses From Equity Investments
—
—
64.78
+638.37%
8.77
Issuance Of Capital Stock
—
20.45
+21.02%
16.90
-9.03%
18.58
Cash Flow From Discontinued Operation
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category